• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于肝细胞癌特征描述的 PET 探针的最新进展。

Recent advances in PET probes for hepatocellular carcinoma characterization.

机构信息

a Department of Nuclear Medicine , Santa Maria Goretti Hospital , Latina , Italy.

b Department of Biomedicine and Prevention , University Tor Vergata , Rome , Italy.

出版信息

Expert Rev Med Devices. 2019 May;16(5):341-350. doi: 10.1080/17434440.2019.1608817. Epub 2019 Apr 28.

DOI:10.1080/17434440.2019.1608817
PMID:30990129
Abstract

INTRODUCTION

Positron Emission Tomography (PET) with F-fluorodeoxyglucose (FDG) presents some limitations for imaging of hepatocellular carcinoma (HCC), the most common primary hepatic malignancy.

AREAS COVERED

The authors discuss the accuracy and limitations of FDG for HCC detection. Then, authors examine the recent advances in PET tracers other than FDG for the biological and prognostic characterization of HCC such as C-acetate, C-choline, and its F-labeled derivatives.

EXPERT COMMENTARY

FDG PET can be helpful for the identification of the more aggressive and poorly differentiated HCC. C-acetate is readily incorporated into intracellular phosphatidylcholine membranes and proved useful for the in vivo biological characterization of the more differentiated and less aggressive HCC. Nevertheless, the short half-life of C- radionuclide limits the clinical application of this compound. C-choline, another surrogate biomarker of cell membrane biosynthesis, has been demonstrated effective for HCC imaging. The availability of choline derivatives labeled with F-radionuclide (i.e. F-fluoroethylcholine, F-fluorocholine) has overcome the drawbacks due to C, thus triggering the clinical applications of choline PET for HCC diagnosis and management. Further research needs to be conducted to better define the alternative or complementary role of these PET probes for the characterization of HCC, with particular regard to the dual-tracer PET-CT modality.

摘要

简介

正电子发射断层扫描(PET)结合 F-氟脱氧葡萄糖(FDG)在诊断肝细胞癌(HCC)方面存在一些局限性,HCC 是最常见的原发性肝恶性肿瘤。

涵盖领域

作者讨论了 FDG 用于 HCC 检测的准确性和局限性。然后,作者研究了 FDG 以外的其他 PET 示踪剂在 HCC 生物学和预后特征分析方面的最新进展,如 C-乙酸盐、C-胆碱及其 F 标记衍生物。

专家评论

FDG PET 有助于识别侵袭性更强、分化程度更低的 HCC。C-乙酸盐可轻易掺入细胞内磷脂酰胆碱膜,已被证明对分化程度更高、侵袭性更低的 HCC 的体内生物学特征具有重要价值。然而,C 放射性核素半衰期较短限制了该化合物的临床应用。C-胆碱是细胞膜生物合成的另一种替代生物标志物,已被证明对 HCC 成像有效。用 F-放射性核素(即 F-氟乙基胆碱、F-氟代胆碱)标记胆碱衍生物克服了 C 的缺点,从而引发了胆碱 PET 用于 HCC 诊断和管理的临床应用。需要进一步研究以更好地确定这些 PET 探针在 HCC 特征分析中的替代或补充作用,特别是在双示踪剂 PET-CT 模式下。

相似文献

1
Recent advances in PET probes for hepatocellular carcinoma characterization.用于肝细胞癌特征描述的 PET 探针的最新进展。
Expert Rev Med Devices. 2019 May;16(5):341-350. doi: 10.1080/17434440.2019.1608817. Epub 2019 Apr 28.
2
Dual-tracer PET/CT imaging in evaluation of metastatic hepatocellular carcinoma.双示踪剂PET/CT成像在转移性肝细胞癌评估中的应用
J Nucl Med. 2007 Jun;48(6):902-9. doi: 10.2967/jnumed.106.036673. Epub 2007 May 15.
3
F-18 FDG in conjunction with 11C-choline PET/CT in the diagnosis of hepatocellular carcinoma.F-18 FDG 联合 11C-胆碱 PET/CT 诊断肝细胞癌。
Clin Nucl Med. 2011 Dec;36(12):1092-7. doi: 10.1097/RLU.0b013e3182335df4.
4
Diagnostic value of combining ¹¹C-choline and ¹⁸F-FDG PET/CT in hepatocellular carcinoma.¹¹C-胆碱与¹⁸F-FDG PET/CT联合应用在肝细胞癌中的诊断价值
Eur J Nucl Med Mol Imaging. 2016 May;43(5):852-859. doi: 10.1007/s00259-015-3241-0. Epub 2015 Nov 18.
5
Can positron emission tomography with the dual tracers [11 C]acetate and [18 F]fludeoxyglucose predict microvascular invasion in hepatocellular carcinoma?正电子发射断层扫描(PET)用双重示踪剂[11C]乙酸盐和[18F]氟脱氧葡萄糖能否预测肝细胞癌中的微血管侵犯?
Liver Transpl. 2011 Oct;17(10):1218-25. doi: 10.1002/lt.22362.
6
PET/CT in patients with hepatocellular carcinoma using [(18)F]fluorocholine: preliminary comparison with [(18)F]FDG PET/CT.使用[(18)F]氟胆碱的肝细胞癌患者的PET/CT:与[(18)F]FDG PET/CT的初步比较
Eur J Nucl Med Mol Imaging. 2006 Nov;33(11):1285-9. doi: 10.1007/s00259-006-0164-9. Epub 2006 Jun 27.
7
A prospective evaluation of 18F-FDG and 11C-acetate PET/CT for detection of primary and metastatic hepatocellular carcinoma.18F-FDG和11C-醋酸盐PET/CT用于检测原发性和转移性肝细胞癌的前瞻性评估。
J Nucl Med. 2008 Dec;49(12):1912-21. doi: 10.2967/jnumed.108.055087. Epub 2008 Nov 7.
8
Detection of hepatocellular carcinoma using 11C-choline PET: comparison with 18F-FDG PET.使用11C-胆碱PET检测肝细胞癌:与18F-FDG PET的比较
J Nucl Med. 2008 Aug;49(8):1245-8. doi: 10.2967/jnumed.108.052639. Epub 2008 Jul 16.
9
Imaging of primary liver tumors with positron-emission tomography.原发性肝癌的正电子发射断层成像
Q J Nucl Med Mol Imaging. 2017 Sep;61(3):292-300. doi: 10.23736/S1824-4785.17.02994-6.
10
11C-acetate PET imaging in hepatocellular carcinoma and other liver masses.11C-乙酸盐PET成像在肝细胞癌及其他肝脏肿块中的应用
J Nucl Med. 2003 Feb;44(2):213-21.

引用本文的文献

1
Development of a Cyclic TMTP1-Based PET Probe for Visualization of Hepatocellular Carcinoma.一种用于可视化肝细胞癌的基于环化TMTP1的正电子发射断层显像(PET)探针的研发
ACS Med Chem Lett. 2025 Mar 26;16(4):617-624. doi: 10.1021/acsmedchemlett.5c00008. eCollection 2025 Apr 10.
2
Prostate-specific membrane antigen-targeting radiopharmaceuticals: a new frontier in hepatic malignancies.前列腺特异性膜抗原靶向放射性药物:肝脏恶性肿瘤治疗的新前沿
Front Oncol. 2025 Mar 7;15:1547459. doi: 10.3389/fonc.2025.1547459. eCollection 2025.
3
Construction of in-situ self-assembled agent for NIR/PET dual-modal imaging and photodynamic therapy for hepatocellular cancer.
构建用于近红外/正电子发射断层扫描双模态成像和光动力治疗肝癌的原位自组装试剂。
J Nanobiotechnology. 2024 Oct 10;22(1):614. doi: 10.1186/s12951-024-02879-6.
4
Preclinical evaluation of Ga-radiolabeled trimeric affibody for PDGFRβ-targeting PET imaging of hepatocellular carcinoma.用于 PDGFRβ 靶向 HCC 正电子发射断层扫描成像的 Ga 标记三聚体亲和体的临床前评估。
Eur J Nucl Med Mol Imaging. 2023 Aug;50(10):2952-2961. doi: 10.1007/s00259-023-06260-x. Epub 2023 May 31.
5
Imaging evaluation following transarterial radioembolization with yttrium-90 microspheres downstaging hepatocellular carcinoma: the first case in China.经动脉注射钇-90微球肝动脉放射性栓塞术使肝细胞癌降期后的影像学评估:中国首例报道
Quant Imaging Med Surg. 2023 Apr 1;13(4):2744-2750. doi: 10.21037/qims-22-943. Epub 2023 Feb 9.
6
Update on PET Radiopharmaceuticals for Imaging Hepatocellular Carcinoma.用于肝细胞癌成像的正电子发射断层显像(PET)放射性药物的最新进展
Cancers (Basel). 2023 Mar 25;15(7):1975. doi: 10.3390/cancers15071975.
7
Comparison between PSMA PET/CT and MRI for Characterizing : A Real-World Study.PSMA PET/CT 与 MRI 对前列腺癌特征分析的比较:一项真实世界研究。
Tomography. 2023 Jan 13;9(1):130-138. doi: 10.3390/tomography9010011.
8
PET/CT with F-choline or F-FDG in Hepatocellular Carcinoma Submitted to Y-TARE: A Real-World Study.接受钇-90微球选择性体内放射治疗的肝细胞癌患者使用氟胆碱或氟脱氧葡萄糖进行PET/CT检查:一项真实世界研究
Biomedicines. 2022 Nov 21;10(11):2996. doi: 10.3390/biomedicines10112996.
9
Imaging Findings of F-Choline and F-DOPA PET/MRI in a Case of Glioblastoma Multiforme Pseudoprogression: Correlation with Clinical Outcome.多形性胶质母细胞瘤假性进展病例中F-胆碱和F-多巴PET/MRI的影像学表现:与临床结果的相关性
Nucl Med Mol Imaging. 2022 Oct;56(5):245-251. doi: 10.1007/s13139-022-00758-2. Epub 2022 Jun 29.
10
PET imaging of hepatocellular carcinoma by targeting tumor-associated endothelium using [Ga]Ga-PSMA-617.使用 [Ga]Ga-PSMA-617 靶向肿瘤相关内皮细胞进行肝细胞癌的 PET 成像。
Eur J Nucl Med Mol Imaging. 2022 Oct;49(12):4000-4013. doi: 10.1007/s00259-022-05884-9. Epub 2022 Jun 28.